Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer
Status:
Recruiting
Trial end date:
2022-07-15
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well low-dose ibuprofen in improving cognitive
impairment in patients with cancer. Anti-inflammatory agents, such as ibuprofen, may slow the
decline of cognitive processes and diseases involving the brain.
Phase:
Phase 2
Details
Lead Sponsor:
Gary Morrow University of Rochester NCORP Research Base